Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 13 min ago
PreprintAll rights reservedbioRxiv

Mural β3-integrin signposts Stroma6, a gene signature predicting early relapse in low-risk and chemoresistant breast cancer

  • A. Jordan
  • V. Anthonydhason
  • K. Baird
  • E. Maniati
  • J. L. Jones
  • I. Wall
  • A. Grigoriadis
  • J. Wang
  • T. AbdelFatah
  • K. Hodivala Dilke1
  1. 1Queen Mary University of London, Barts Cancer Institute
Read full textPDFDOICite

Related

  1. Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
    Yuzhi Zheng, Xinnuo Chen, Zijian Wu +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. A T-cell exhaustion-related signature for predicting response to immunotherapy among patients with lung adenocarcinoma
    Chengcheng Yang, Zefeng Wang, Jintao Xie +4
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma.
    Wenhao Hu, Dute Gao, Guojun Hou +4
    Journal of hepatocellular carcinomaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. A Pathological Image-Based Pathomics Signature Combined with Clinicopathological Features for Predicting Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma: A Development and External Validation Study
    Kaiming Peng, Jieming Lu, Peipei Zhang +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia
    Mohammad Javad NajafPanah, Alexandra M. Stevens, Michael J. Krueger +15
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@misc{jordan2026mural,
  title = {{Mural β3-integrin signposts Stroma6, a gene signature predicting early relapse in low-risk and chemoresistant breast cancer}},
  author = {A. Jordan and V. Anthonydhason and K. Baird and E. Maniati and J. L. Jones and I. Wall and A. Grigoriadis and J. Wang and T. AbdelFatah and K. Hodivala Dilke},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.10.750700},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750700v1},
}
RIS
TY  - UNPB
TI  - Mural β3-integrin signposts Stroma6, a gene signature predicting early relapse in low-risk and chemoresistant breast cancer
AU  - A. Jordan
AU  - V. Anthonydhason
AU  - K. Baird
AU  - E. Maniati
AU  - J. L. Jones
AU  - I. Wall
AU  - A. Grigoriadis
AU  - J. Wang
AU  - T. AbdelFatah
AU  - K. Hodivala Dilke
PY  - 2026
DA  - 2026/09/10
PB  - bioRxiv
DO  - 10.64898/2026.09.10.750700
UR  - https://www.biorxiv.org/content/10.64898/2026.09.10.750700v1
ER  -